Ventyx Biosciences, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
|---|---|---|---|---|
ASND
Ascendis Pharma A/S |
$162.84 | $9.83 B | -24.71 | 1017 |
CERE
Cerevel Therapeutics Holdings, Inc. |
$44.96 | $8.19 B | -16.47 | 355 |
GPCR
Structure Therapeutics Inc. |
$21.76 | $429.22 M | -8.67 | 163 |
IMCR
Immunocore Holdings plc |
$36.60 | $1.76 B | -81.56 | 493 |
IDYA
IDEAYA Biosciences, Inc. |
$19.89 | $1.76 B | -5.5 | 131 |
PCVX
Vaxcyte, Inc. |
$32.49 | $4.23 B | -8.22 | 414 |
SNDX
Syndax Pharmaceuticals, Inc. |
$10.54 | $914.68 M | -2.76 | 270 |
TVTX
Travere Therapeutics, Inc. |
$15.02 | $1.37 B | -5.53 | 385 |
UTHR
United Therapeutics Corporation |
$318.85 | $14.47 B | 12.78 | 1305 |
NUVL
Nuvalent, Inc. |
$74.61 | $5.37 B | -16.91 | 162 |
REPL
Replimune Group, Inc. |
$8.98 | $723.84 M | -3.06 | 331 |
PTGX
Protagonist Therapeutics, Inc. |
$47.47 | $2.95 B | 61.01 | 124 |
ACLX
Arcellx, Inc. |
$62.06 | $3.42 B | -20.74 | 163 |
VRNA
Verona Pharma plc |
$81.20 | $6.58 B | -38.73 | 209 |
DICE
DICE Therapeutics, Inc. |
$47.55 | $2.27 B | -21.91 | 71 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
